摘要 |
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (Ia) and (Ib) where R1, R2, R3, R4, R5, R6, R8, R9 and X aredefined herein. The compoundsare useful for treating autoimmune and other diseases. Also disclosed are processes for making such novel compounds. |
申请人 |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. |
发明人 |
BEKKALI, YOUNES;HICKEY, EUGENE, R.;WEIMIN, LIU;PATEL, USHA, R.;SPERO, DENICE, MARY;SUN, SANXING;THOMSON, DAVID, S.;WARD, YANCEY, D.;YOUNG, ERICK, R., R. |